1. Cyclosporin - interactions of clinical significance

   Newsletter Article 16 February 2013 Pages: 2 - 2

2. Penicillin allergy or pseudoanaphylaxis?

   Newsletter Article 16 February 2013 Pages: 2 - 3

3. Diagnosis of heavy metal poisoning

   Newsletter Article 16 February 2013 Pages: 3 - 3

4. Cardiovascular effects of antidepressants

   Newsletter Article 16 February 2013 Pages: 3 - 4

5. Alfentanil

   Newsletter Article 16 February 2013 Pages: 4 - 4

6. Alteplase

   Newsletter Article 16 February 2013 Pages: 4 - 4

7. Anaesthetics

   Newsletter Article 16 February 2013 Pages: 5 - 5

8. Anticonvulsants

   Newsletter Article 16 February 2013 Pages: 5 - 5

9. Atenolol see Propranolol/atenolol

   Newsletter Article 16 February 2013 Pages: 5 - 5

10. Aurothioglucose/aurothiomalate

    Newsletter Article 16 February 2013 Pages: 5 - 5

11. Aurothiomalate see Aurothioglucose/aurothiomalate

    Newsletter Article 16 February 2013 Pages: 5 - 5

12. Azathioprine

    Newsletter Article 16 February 2013 Pages: 5 - 5

13. Bucladesine

    Newsletter Article 16 February 2013 Pages: 5 - 5

14. Caffeine

    Newsletter Article 16 February 2013 Pages: 5 - 6

15. Captopril

    Newsletter Article 16 February 2013 Pages: 6 - 6

16. Cocaine

    Newsletter Article 16 February 2013 Pages: 6 - 6

17. Cocaine overdose

    Newsletter Article 16 February 2013 Pages: 6 - 6

18. Cyclosporin

    Newsletter Article 16 February 2013 Pages: 6 - 6

19. Cyclosporin see Norfloxacin interaction

    Newsletter Article 16 February 2013 Pages: 6 - 6

20. Cyclosporin interaction

    Newsletter Article 16 February 2013 Pages: 6 - 6

21. Deferoxamine

    Newsletter Article 16 February 2013 Pages: 6 - 7

22. Desmopressin

    Newsletter Article 16 February 2013 Pages: 7 - 8

23. Enoxacin see Fenbufen interaction

    Newsletter Article 16 February 2013 Pages: 8 - 8

24. Ergocalciferol overdose

    Newsletter Article 16 February 2013 Pages: 8 - 8

25. Fenbufen interaction

    Newsletter Article 16 February 2013 Pages: 8 - 8

26. Fentanyl

    Newsletter Article 16 February 2013 Pages: 8 - 9

27. Flunarizine

    Newsletter Article 16 February 2013 Pages: 9 - 9

28. Fluorouracil

    Newsletter Article 16 February 2013 Pages: 9 - 9

29. Gentamicin

    Newsletter Article 16 February 2013 Pages: 9 - 9

30. H2-antagonists

    Newsletter Article 16 February 2013 Pages: 9 - 9

31. Indomethacin

    Newsletter Article 16 February 2013 Pages: 9 - 10

32. Ketoprofen

    Newsletter Article 16 February 2013 Pages: 10 - 10

33. Methotrexate

    Newsletter Article 16 February 2013 Pages: 10 - 10

34. Mezlocillin see Tobramycin/mezlocillin

    Newsletter Article 16 February 2013 Pages: 10 - 10

35. Midazolam

    Newsletter Article 16 February 2013 Pages: 10 - 10

36. Nifedipine

    Newsletter Article 16 February 2013 Pages: 10 - 10

37. Norfloxacin interaction

    Newsletter Article 16 February 2013 Pages: 10 - 10

38. Propranolol/atenolol

    Newsletter Article 16 February 2013 Pages: 10 - 10

39. Propylene glycol

    Newsletter Article 16 February 2013 Pages: 10 - 10

40. Retinoids

    Newsletter Article 16 February 2013 Pages: 10 - 10

41. Rifampicin

    Newsletter Article 16 February 2013 Pages: 10 - 10

42. Ritodrine

    Newsletter Article 16 February 2013 Pages: 10 - 10

43. Sulindac

    Newsletter Article 16 February 2013 Pages: 10 - 11

44. Sulpiride

    Newsletter Article 16 February 2013 Pages: 11 - 11

45. Suxamethonium

    Newsletter Article 16 February 2013 Pages: 11 - 11

46. Thiopronine

    Newsletter Article 16 February 2013 Pages: 11 - 11

47. Tobramycin/mezlocillin

    Newsletter Article 16 February 2013 Pages: 11 - 12

48. Vaccine, typhoid

    Newsletter Article 16 February 2013 Pages: 12 - 12

49. Verapamil see Cyclosporin interaction

    Newsletter Article 16 February 2013 Pages: 12 - 12

50. Salicylates and Reye’s Syndrome

    Newsletter Article 16 February 2013 Pages: 12 - 12